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Microbial-derived natural products are important in both the pharmaceutical industry and academic
research. As the metabolic potential of original producer especially Streptomyces is often limited by slow
growth rate, complicated cultivation proﬁle, and unfeasible genetic manipulation, so exploring a Strep-
tomyces as a super industrial chassis is valuable and urgent. Streptomyces sp. FR-008 is a fast-growing
microorganism and can also produce a considerable amount of macrolide candicidin via modular pol-
yketide synthase. In this study, we evaluated Streptomyces sp. FR-008 as a potential industrial-production
chassis. First, PacBio sequencing and transcriptome analyses indicated that the Streptomyces sp. FR-008
genome size is 7.26 Mb, which represents one of the smallest of currently sequenced Streptomyces ge-
nomes. In addition, we simpliﬁed the conjugation procedure without heat-shock and pre-germination
treatments but with high conjugation efﬁciency, suggesting it is inherently capable of accepting heter-
ologous DNA. In addition, a series of promoters selected from literatures was assessed based on GusA
activity in Streptomyces sp. FR-008. Compared with the common used promoter ermE*-p, the strength of
these promoters comprise a library with a constitutive range of 60e860%, thus providing the useful
regulatory elements for future genetic engineering purpose. In order to minimum the genome, we also
target deleted three endogenous polyketide synthase (PKS) gene clusters to generate a mutant LQ3. LQ3
is thus an “updated” version of Streptomyces sp. FR-008, producing fewer secondary metabolites proﬁles
than Streptomyces sp. FR-008. We believe this work could facilitate further development of Streptomyces
sp. FR-008 for use in biotechnological applications.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Microbial-derived natural products exhibit a diverse array of
unique structures and biological activities, such as antibacterial,
antifungal, antitumor, and immunosuppressant activities [1].
However, genetically engineering microbial strains to overproduce
desired products was often limited by recalcitrance to genetic
manipulation, poor growth characteristics, as well as limited un-
derstanding of a given strain's cultivation proﬁle. Heterologous
expression has been used as a strategy to overcome theseunications Co., Ltd.
ng by Elsevier B.V. on behalf of KeAlimitations by providing a more amenable, well-characterized
chassis for the production of natural products [2]. This method
has also been proven a powerful tool for mining the metabolic
potential of difﬁcult-to-culture microorganisms and expressing
cryptic gene clusters, particularly in the postgenomic age [3,4].
One of the most crucial steps in the design of a heterologous
expression system is the choice of a suitable host, which is usually
determined heuristically. Escherichia coli and Saccharomyces cer-
evisiae are often used as general hosts, but heterologous expression
of complex natural products in these host organisms often results
in low titer and limits the types of chemicals [5]. These limitations
are generally considered to be due to differences in the
morphology, physiology, metabolism, and regulatory mechanisms
between the above-mentioned hosts and the native producer,
which is often an actinomycetes species [6]. Due to their similarityi Communications Co. This is an open access article under the CC BY-NC-ND license
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expressing these compounds. To our knowledge, four Streptomyces
species are commonly used, including Streptomyces lividans,
Streptomyces coelicolor, Streptomyces avermitilis, and Streptomyces
albus J1074. Streptomyces coelicolor is considered as the model
strain and was used in development of the earliest genetic re-
combinant techniques for heterologous gene transfer [7,8]. Strep-
tomyces lividans, which is a plasmid-containing derivative of
S. coelicolor that shares considerable genome sequence similarity, is
often used for exogenous production of natural products. De-
rivatives of S. lividans and S. coelicolor in which the native biosyn-
thesis pathways have been knocked out include S. coelicolor CH999
and S. lividans K4-114 [9,10]. And S. coelicolorM1152 &M1154 with
impressing manipulation on ribosome is successfully applied for
improvement of natural product titers [11]. Streptomyces avermitilis,
for which the genome sequence has been determined, is capable of
producingmacrolactone insecticides known as avermectins [12,13].
Several S. avermitilis derivatives have been constructed in which a
1.4-Mb region of the 9.02-Mb linear chromosome has been deleted
[14], and these strains have been evaluated based on the expression
of 20 gene clusters [15]. Streptomyces albus J1074 is another
commonly used Streptomyces host. Recent sequencing of the
complete genome of S. albus revealed that at 6.84 Mb, it is the
smallest Streptomyces genome determined thus far [16].
Although there are many reports of successful heterologous
expression in the above-mentioned hosts, production sometimes
fails when different hosts are employed [17], and it is difﬁcult to
predict what percentage of experiments will fail. There is, there-
fore, an urgent need for a standardized platform involving an efﬁ-
cient and reliable host organism to maximize the chances of
successful heterologous expression. An optimal host should not
only exhibit excellent growth characteristics and be readily
amenable to genetic manipulation, but its genotype should also be
consistent with the synthesis of molecules of the type and
complexity of the product of interest. In addition, unfavorable or
unnecessary elements of the genome should be removed when
developing an organism as a microbial chassis [18].
In this study, Streptomyces sp. FR-008 was selected as a potential
host organism for use as a chassis for heterologous expression.
Streptomyces sp. FR-008 originated from the random protoplast
fusion of two Streptomyces strains derived from Streptomyces
hygroscopicus var. yingchengensis n. var. [19]. The mutant Strepto-
myces sp. FR-008 reportedly exhibits greater production of anti-
bacterial factors than its parent strains and has been investigated
extensively with respect to biosynthesis of the macrolide antibiotic
candicidin. The candicidin biosynthesis gene cluster is 130-kb in
size, and synthesis of candicidin involves a type I polyketide [20],
suggesting that this organism can accommodate large biosynthetic
machinery. More importantly, Streptomyces sp. FR-008 can produce
0.4 mg/L of candicidin via 3-days shake-ﬂask fermentation in yeast
extract-malt extract (YEME)medium [21], a medium normally used
for growing Streptomyces rather than for fermentation. In addition,
Streptomyces sp. FR-008 grows rapidly, which is a valuable char-
acteristic for a chassis organism.
To evaluate the potential of Streptomyces sp. FR-008 as a host for
heterologous expression, the genome was ﬁrst thoroughly charac-
terized via PacBio sequencing and transcriptome analysis. In addi-
tion, a simpliﬁed conjugationmethod was developed and promoter
element usage was assessed. Finally, all three endogenous polyke-
tide biosynthesis gene clusters, comprising 150-kb of the chro-
mosome, including the candicidin biosynthesis gene cluster, were
knocked out in the absence of resistance markers to generate a
relatively clean host free of polyketide competition. Based on these
experiments, we were able to engineer Streptomyces sp. FR-008 to
serve as a chassis with a simpliﬁed, less complex genotypicbackground. The organism can be further engineered via gene
transfer and promoter element selection as a platform for heter-
ologous expression of desired products.
2. Materials and methods
2.1. Microorganisms, plasmids, and culture conditions
Details regarding the bacterial strains and plasmids used in this
study are provided in Table S1. The primers used in the study are
listed in Table S2. Streptomyces sp. FR-008 was obtained from the
collection of Professor Zixin Deng [20]. E. coli ET12567, harboring
pUZ8002, was used as a vector donor for intergeneric conjugation
[22]. All E. coli strains were cultivated in LB medium, whereas soy
ﬂour mannitol (SFM) solid medium (2% agar, 2% mannitol, 2%
soybean powder [pH 7.2]) and 3% tryptone soy broth (TSB) (pH 7.2)
liquid medium were used to cultivate Streptomyces strains and
mutants. Fermentation was performed in liquid YEME medium
(0.3% yeast extract, 0.5% Bacto-peptone, 0.3% malt extract, 1%
glucose, 10.3% sucrose [pH 7.2]). E. coli strains were grown at 37 C,
and Streptomyces strains were cultured at 30 C.
2.2. Complete genome sequencing and assembly
The PacBio sequencing platform was utilized for determining
the genome sequencing of Streptomyces sp. FR-008 [23]. First, gDNA
was fragmented to an average size of 10 kb and sequenced using
PacBio RSII. Nine single-molecule real-time sequencing (SMRT)
cells were used for each 3-h sequencing reaction. The PacBio
consensus calling feature was used for correction of PacBio long
reads, and the reads were assembled according to the Hierarchical
Genome Assembly Process (HGAP) method [24]. An interpolated
Markov model was used for whole-genome gene predictions.
Protein-coding sequences (CDSs) were scanned using GLIMMER 3.0
[25], and their functions were predicted based on BLASTP homol-
ogy searching under the following criteria: alignment of E-values,
<1e5; identity, >35%. Each gene was cataloged according to bio-
logical function in the cluster of orthologous groups (COG) data-
base. Additionally, genes involved in secondary metabolite
production were identiﬁed using antiSMASH 3.0 online software
[26]. Data regarding the complete genome of Streptomyces sp. FR-
008 were submitted to GenBank under accession numbers
CP009802eCP009804.
2.3. Biomass measurement
Cell density was determined by measuring dry cell weight
(dcw). A 2-mL culture was collected in a pre-weighed Eppendorf
tube and immediately centrifuged at 10,000  g for 20 min at 4 C.
The residual cells were washed twice with distilled water and then
the supernatant was discarded. The pellet was dried to a constant
weight at 105 C, and the mass gain was measured.
2.4. Transcriptome sequencing
Cell pellets were rapidly harvested by centrifugation and ﬂash
frozen in liquid nitrogen. Total RNA was extracted using a bacteria
kit (SBS Genetech Inc., Beijing, China). SuperScript II reverse tran-
scriptase (Invitrogen, Carlsbad, CA) and a TruSeq RNA sample prep
kit v2 (Illumina) were used for the ﬁrst- and second-strand cDNA
synthesis. Library puriﬁcation was performed using AMPure XP
beads (Beckman), and quality was veriﬁed using an Agilent 2100
Bioanalyzer (Agilent Technologies, High Sensitivity DNA kit) and a
Qubit® 2.0 ﬂuorometer (Invitrogen, dsDNA HS Assay kit).
Sequencing cluster generation and sequencing were performed on
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(Shanghai, China). A single-end, 50-bp sequencing strategy was
employed, and more than 89 million reads for each sample were
sequenced using a Hiseq 2500 system (Illumina). Reads were
aligned to the genome of Streptomyces sp. FR-008 using SOAP-
aligner/soap2 (version 2.21) with only unique matches, and the
transcript level of each sample was quantiﬁed as reads per kilobase
per million mapped reads (RPKM) [27]. Further comparisons be-
tween samples were normalized by taking the log2 of the RPKM
value. The RNA-Seq data were submitted to the NCBI under
accession number SRX1022665.
2.5. Conjugation
To optimize the conjugation procedure, the shuttle vector
pIB139 [28] was transferred to E. coli ET12567/pUZ8002 by elec-
troporation. A single colony was picked, cultured overnight, and
then inoculated at a 1:10 dilution in fresh LB medium and cultured
until the OD600 reached 0.8. These cells served as the donors. Spores
harvested from an SFM plate were subjected to streamlined heat-
shock (50 C, 10 min) and pre-germination (37 C, 2 h) steps to
prepare them for use as recipient cells. The recipient and donor
cells were counted using a dilution plating method and then mixed
at various ratios and inoculated onto an SFM plate supplemented
with 20 mM MgCl2. The plate was incubated at 30 C for 11 h and
then overlaid with 1 mL of sterile water containing apramycin and
nalidixic acid. Approximately 30 h later, white exconjugants were
detected. Several exconjugants were picked into TSB liquidmedium
with apramycin and then examined by PCR to conﬁrm the presence
of apramycin-resistance genes (using the primer pairs Apr-checkF
and Apr-checkR).
2.6. Gene knockout
For targeted gene knockout, pJTU1278 was used on the basis of
homologous recombination [29]. First, the two ﬂanking arms were
designed using Primer Premier5, with an additional digestion site
included for cloning (primer pairs LA1-F/LA1-R and RA1-F/RA1-R
for constructing LQ1; primer pairs LA2-F/LA2-R and RA1-F/RA1-R
for constructing LQ2; and primer pairs LA3-F/LA3-R and RA1-F/
RA1-R for constructing LQ3). The pJTU1278-derived construct was
generated through cloning, with the apramycin-resistance marker
included between the ﬂanking arms. This construct was trans-
formed into E. coli ET12567/pUZ8002 for ﬁrst-round conjugation.
Thiostrepton-resistant exconjugants were selected as single-
crossover mutants. After sporulation on SFM medium without
antibiotic selection, double-crossover mutants were selected based
on thiostrepton-sensitive and apramycin-resistant and then veri-
ﬁed by PCR analysis with ﬂanking primers (primer pairs Check-F1
and Check-R1 for verifying LQ1, Check-F2 and Check-R2 for veri-
fying LQ2, and Check-F3 and Check-R3 for verifying LQ3). In the
next round of conjugation, the same ﬂanking arms were ligated
into pJTU1278. The thiostrepton-resistant exconjugants were
selected as single-crossover mutants. After nonselective growth,
apramycin- and thiostrepton-sensitive mutants were selected as
targeted knockout mutants without the use of resistance markers.
The genotype of the mutants was veriﬁed by PCR analysis with the
ﬂanking primers used in the ﬁrst-round conjugation.
2.7. Test of promoter strength based on GusA activity
A total of 20 promoters were selected for evaluation based on
previous reports and synthesized by Genewiz Corp. (Suzhou, China)
[30e32] (Table S3). The promoters were then cloned into pSET152
[33] upstream of the gusA reporter gene by simple cloning. Theresulting constructs (pLH1epLH20) were transformed into Strep-
tomyces sp. FR-008 using the simpliﬁed conjugation method
developed in this study. Positive exconjugants were picked into TSB
liquid medium containing apramycin, and introduction of gusAwas
veriﬁed by PCR ampliﬁcation with primer pairs Gus-F and Gus-R.
The selective strength of the promoter harbored by each trans-
formant was assessed based on the enzymatic activity of the re-
porter protein GusA, according to a previous report [34].
3. Results
3.1. Complete Streptomyces sp. FR-008 genome sequence
In order to obtain the detailed genetic information, the complete
genome sequence of Streptomyces sp. FR-008 was determined using
PacBio single-molecule real-time sequencing. Using the updated
PacBio RSII, nine SMRTcells yielded 1.40 Gb of raw data (N50 length
7604 bp) in a 3-h sequencing reaction. Genome assembly per-
formed directly from the PacBio data yielded three contigs (Fig. 1;
GenBank accession numbers CP009802eCP009804). In addition to
the linear chromosome, Streptomyces sp. FR-008 harbors two linear
plasmids: pHZ227 and pHZ228. With a total length of 7,258,032 bp,
the Streptomyces sp. FR-008 genome is one of the smallest Strep-
tomyces genomes thus far reported.
Basic information regarding the Streptomyces sp. FR-008
genome is shown in Table 1. The linear chromosome is comprised
of 6920 predicted CDSs, with an average G þ C content of 73.41%.
The replication origin, oriC, is located near the middle of the
chromosome. In comparison to other sequenced Streptomyces
chromosomes, the center essential “core region” of the Strepto-
myces sp. FR-008 chromosome was predicted to be relatively small,
at 5.56 Mb. The two linear plasmids, pHZ227 and pHZ228, contain
180 and 27 CDSs, respectively. It should be noted that the chro-
mosomewas found to lack the conserved dnd genes responsible for
DNA phosphothiolation. In addition, along with the CRISPR-Cas
bacterial immune system, a set of genes involved in arsenic resis-
tance was identiﬁed on pHZ227 [35]. These components may
protect the cells against the toxic effects of arsenic, as well as
damage from exogenesis sources, including phages and other
invasive genetic elements.
For a more in-depth analysis of the Streptomyces sp. FR-008
genome, COG function category and antiSMASH analyses were
carried out [26] (Fig. S1). The highest proportion of genes was found
to be that involved in transcription (11%), and genes associatedwith
12 diverse regulatory families were identiﬁed, providing evidence
of an inherent multi-level transcription regulatory network in
Streptomyces sp. FR-008. The global transcript gamma-
butyrolactone system was not identiﬁed in the Streptomyces sp.
FR-008 genome, however. The second richest COG category
included genes involved in carbohydrate (9%) and amino acid (8%)
transport and metabolism. In addition, nearly 6% of CDSs were
found to be associated with transport systems, primarily the ATP-
binding cassette (ABC) and major facilitator superfamily trans-
porters. Moreover, a combined antiSMASH analysis and NCBI ho-
mology search revealed 23 putative secondary metabolic gene
clusters on the Streptomyces sp. FR-008 chromosome, which is
consistent with the high biosynthesis potential of most Strepto-
myces (Table S4). Eleven of the 21 putative secondary metabolite
gene clusters were found to be involved in non-ribosomal peptide
synthetases/polykeide (NRPS/PKS) biosynthesis, two of which was
deﬁned as encoding type I PKS and the other as encoding type III
PKS. Compared with other annotated Streptomyces genomes, that of
Streptomyces sp. FR-008 encodes a relatively small PKS gene pool,
which may explain the strain's efﬁcient production of the macro-
lide candicidin with minimal homologous competition.
Fig. 1. Schematic representation of the Streptomyces sp. FR-008 chromosome and the two linear plasmids. (A) The chromosome atlas. From the outside in, circles 1 and 2: predicted
genes (reverse and forward strands, respectively) colored according to cluster of orthologous groups (COG) function categories; circle 3: essential genes (cell division and chro-
mosome partitioning, replication, transcription, translation, amino acid/nucleotide transport and metabolism, color coding as for circles 1 and 2); circle 4: biosynthetic gene clusters
(three PKS gene clusters are labeled in orange); circle 5: tRNA and rRNA (deep blue and brown, respectively); circle 6: GC content; circle 7: GC skew ([G e C/G þ C], khaki indicates
values > 0, purple values < 0). (B) and (C) Atlases of linear plasmids pHZ227 and pHZ228, respectively. Circles 1 and 2: predicted genes (reverse and forward strands, respectively)
colored according to COG function categories; circle 3: essential genes (cell division and chromosome partitioning, replication, transcription, translation, amino acid/nucleotide
transport and metabolism, color coding as for circles 1 and 2); circle 4: GC content; circle 5: GC skew (G  C/G þ C).
Table 1
General features of the complete genome sequence of Streptomyces sp. FR-008.
Value Chromosome pHZ227 pHZ228
Topology Linear Linear Linear
Length (bp) 7, 090, 956 142, 804 24, 272
GC content (%) 73.41% 69.34% 72.87%
CDS (no.) 6920 178 29
Coding (%) 76.10% 37.78% 25.91%
rRNA operon (no.) 7
tRNA (no.) 65 (43 species)
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Genome annotation analyses were augmented by comprehen-
sive transcriptional proﬁling using RNA-Seq analysis of Strepto-
myces sp. FR-008 over time. Cells were grown in liquid TSB medium
and harvested at four time points: 14, 18, 24, and 36 h, representing
the lag, exponential, transitional, and stationary growth phases,
respectively (Fig. S2). As reported, the chromosome site of heter-
ologous gene integration could affect gene expression as a conse-
quence to inﬂuence targeted production [36]. To locate the
chromosomal region exhibiting high expression, we conducted a
global transcriptome analysis (Fig. 2). The majority of genes that
maintained a high expression level at all four time points examined
was found to be involved in translation and energy production andwas located on different regions of the chromosome. Besides, in-
dividual genes keep at highly expression levels under all four time
points can be selected as candidate of strong constitutive pro-
moters as reported in S. albus J1074 case [32]. Here, we selected top
1% of the most highly expressed genes as conclude in Table S5. And
the promoter sequence upstream of these 1% cutoff genes can be
predictable by bioinformatics tools [37], in order to generate a
panel of strong constitutive promoters.
The expression proﬁles of 23 predicted gene clusters were also
examined (Fig. S3). The results showed that the expression of ﬁve
NRPS-related gene clusters began during different growth phases.
The expression of candicidin biosynthesis genes began before the
lag phase and continued until the stationary phase, consistent with
the short fermentation time observed in a previous experiment
[21]. Expression of transcripts for other secondarymetabolite genes
was weak or absent in cells grown under these conditions in TSB
medium. In addition, based on hypergeometric distribution and
COG functional enrichment, the up- or down-regulated genes were
assigned to 21 functional groups (Fig. S4). Genes involved in
metabolism of amino acids, nucleotides, and inorganic ions were all
up-regulated before the exponential phase and then down-
regulated in the stationary phase. In contrast, genes involved in
carbohydrate metabolism were up-regulated in the stationary
phase, suggesting that there is a high demand for carbohydrate
products during the later growth stages compared with earlier
Fig. 2. Global view of gene expression proﬁles through physical location of chromosome. The X-axis is indicated the site on chromosome, and the Y-axis is indicated the gene
expression value of RPKM based on RNA-Seq data.
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transcription were markedly up-regulated in the stationary phase,
indicating that speciﬁc transcription regulators play important
roles in regulating metabolism during the late stages of growth.3.3. Genetic manipulation
Various practical challenges have limited the genetic manipu-
lation of actinomyces. Based on the high conjugation efﬁciency of
Streptomyces sp. FR-008 observed in our past work, in the present
study, we sought to optimize its conjugation procedure, focusing on
the heat-shock and pre-germination steps of recipient. First, the
optimal ratio of donor to recipient cells was assessed. The results of
these analyses showed that an equal ratio provided the highest
conjugation efﬁciency (Table S6). Thus, subsequent optimizations
were carried out at an equal donor to recipient ratio. We then
examined the effect of omitting the heat-shock treatment of
recipient spores. Surprisingly, omitting the heat-shock step had no
signiﬁcant effect on efﬁciency. Similar optimization analyses of the
pre-germination steps were performed, and the results showed
that omitting the pre-germination steps also had no appreciable
effect on conjugation efﬁciency. The conjugation efﬁciency afforded
by this simpliﬁed procedure involving only the mixing of donors
and acceptors, without the heat-shock and pre-germination steps
(Fig. 3), was approximately 20% higher (Table 2). Notably, due to the
rapid growth rate of Streptomyces sp. FR-008, the time required for
the appearance of exconjugants or resistance selectionwas reduced
to approximately 30 h, far less than the 3e5 days required for most
Streptomyces strains.Fig. 3. Schematic diagram of workﬂow for comparing the simpliﬁed and general conjugation
each step. The procedures in the dashed box included the heat-shock and pre-germination
study.3.4. Assessment of promoter strength in the host
In engineering a heterologous expression pathway, a panel of
well-characterized strong promoters is typically used to ﬁne-tune
expression of the desired genes. Previously, the promoter ermEp
was the only available option for Streptomyces sp. FR-008 [21,38].
Recently, however, synthetic promoters stronger than ermEp have
been used to overproduce various natural products [30,39]. To
provide more promoter options for Streptomyces sp. FR-008, we
chose 20 strong promoters as candidates and evaluated them with
respect to regulation of GusA activity in Streptomyces sp. FR-008.
The selected promoters played different regulatory roles, included
promoters derived from temporally expressed kasOp for a SARP
family regulator in S. coelicolor [30,31], and constitutive promoters
identiﬁed through transcriptome analyses in S. albus J1074 [32]
(Table S3). These promoters exhibited reproducible and homoge-
neous activity ranging from 60 to 860% of the activity of ermE*-p
(Fig. 4).
3.5. Streamlining the Streptomyces sp. FR-008 genome by knockout
of PKS gene clusters
Candicidin is the main secondary metabolite of Streptomyces sp.
FR-008 [20]. To generate a smaller and more streamlined genome
encoding a minimum of extracellular metabolites, we deleted all of
the PKS genes in Streptomyces sp. FR-008. Analyses of the complete
genome identiﬁed three PKS gene clusters. The type I PKS cluster is
responsible for candicidin biosynthesis. Although the compounds
produced by another type I and type III PKS clusters are unknown, it
is necessary to remove similar genes to generate a clean polyketideprocedures. Refer to the text in the corresponding sections for detailed descriptions of
steps, which were omitted in the simpliﬁed conjugation procedure developed in this
Table 2
Conjugation efﬁciency at different recipient treatments omitted with heat-shock or pre-germinationa.
Donor Conjugation efﬁciency with different recipient treatments (  106)
Heat-shock (þ) pre-germination
(þ)
Heat-shock (þ) pre-germination
()
Heat-shock () pre-germination
(þ)
Heat-shock () pre-germination
()
E. coli ET12567 (pUZ8002)/
pIB139
1.64 ± 0.19 1.56 ± 0.18 1.68 ± 0.16 2.07 ± 0.17
a All data are mean values of three independent experiments, and the error bars indicate the standard deviation.
Fig. 4. Strength of selected promoters in Streptomyces sp. FR-008. The strength of each
promoter (black bars) was assessed based on GusA activity. All data are mean values of
three independent experiments, and error bars indicate the standard deviation.
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region” in Streptomyces sp. FR-008, it is difﬁcult to predict whether
deletion of a large segment of the genome would result in a sig-
niﬁcant change in the chromosome structure. Therefore, we pro-
ceeded cautiously, sequentially deleting the targeted PKS genes. As
shown in Fig. S5, all three PKS gene clusters were sequentially
deleted, producing strains LQ1, LQ2, and LQ3. The genes were
deleted in the following order: candicidin biosynthesis gene cluster,
SFR6781 (type III PKS), and SFR6902eSFR6904 (type I PKS). Com-
plete deletion of these gene clusters and joining of the neighboring
sequences were conﬁrmed by PCR analysis (Fig. S5). The genome of
host LQ3 was streamlined by the removal of nearly 156 kb of the
genome sequence while avoiding the competing sinks of metabolic0
20
40
60
80
0 20 40 60 80
S. FR-008
LQ3
S. albus J1074
S. avermitilis NRRL8165
S. coelicolor A3(2)
S. lividans TK24
18 h
S. FR-008
LQ3
S. albus
J1074
S. avermitilis
NRRL8165
S. coelicolor
A3(2)
S. lividans
TK24
BA
Time (h)
D
ry
 c
el
l w
ei
gh
t (
m
g/
m
L
)
Fig. 5. Comparison of growth phenotype and high-performance liquid chromatography proﬁ
of Streptomyces sp. FR-008 and LQ3 along with four other general Streptomyces hosts grown
along with four other general Streptomyces hosts grown on SFM agar medium. (C) High-per
008 and LQ3 cultured in YEME liquid medium for 4 days. Peaks labeled V, III, and VI are
components in the extracts of the wild-type. mAU, milliabsorbance units.ﬂux and enabling the characterization of transfer of exogenous
gene clusters. It should also be noted that in construction of LQ2, in
which the type III PKS was deleted, we obtained the targeted
double-crossover mutant without ﬁrst distinguishing the single-
crossover mutant, illustrating that the host is amenable to genetic
manipulation.
We examined the growth and sporulation characteristics of host
LQ3 in comparison with the parental strain and four other widely
used hosts. LQ3 exhibited a slightly higher growth rate than
Streptomyces sp. FR-008 in TSB liquid medium, reaching a higher
biomass yield in a shorter time (Fig. 5A). However, both strains
exhibited similar sporulation rates on SFM agar plates (Fig. 5B).
Under the conditions used here, Streptomyces sp. FR-008 and LQ3
exhibited the best growth proﬁles of all the strains examined. YEME
medium, typically used for candicidin fermentation, was used to
compare the production of secondary metabolites by Streptomyces
sp. FR-008 and LQ3. High-performance liquid chromatography
analysis of whole-broth ethyl acetate extracts conﬁrmed the
absence of major endogenous metabolites (Fig. 5C).
To further evaluate differences between wild type Streptomyces
sp. FR-008 and LQ3, RNA sequencing was employed to analyze their
gene expression proﬁles in the stationary phase, when the majority
of secondary metabolites are produced. Overall, 101 genes were
either up- or down-regulated at least 2-fold in LQ3 (39 genes were
up-regulated and 62 genes were down-regulated). Most of these
genes (66/101) were found to encode hypothetical proteins. Genes
encoding ABC transporter permease and CoA synthetase were
slightly up-regulated, and genes encoding some transporter and
transmembrane proteins were down-regulated, with weak
expression in LQ3. No expression of PKS genes was detected, veri-
fying the clean PKS background of LQ3. Thus, the targeted deletion
of PKS to produce mutant LQ3 did not affect transcription from a
global perspective. These data suggested that the genome of LQ3 is
stable under the conditions examined in this study.15 h
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formance liquid chromatography traces of ethyl acetate extracts of Streptomyces sp. FR-
indicated as candicidin-V, eIII, and eVI respectively, which are three main candicidin
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The results of a previous study showed that several Streptomyces
strains and corresponding deletion mutants were suitable for use
as chassis for industrial biosynthesis [2,5]. Due to the differences in
mechanism and requirements for each type of biosynthesis, and the
complex nature of metabolic regulation, a well-deﬁned chassis for
improved heterologous expression is desirable. Hence, in this study,
we focused on engineering a chassis derived from Streptomyces sp.
FR-008.
Through PacBio sequencing, the complete Streptomyces sp. FR-
008 genome was assembled directly into three contigs, suggest-
ing that this sequencing platform and assembly method are ideally
suited for GC-rich species. It was surprising to ﬁnd that the size of
the Streptomyces sp. FR-008 genomewas naturally minimized, with
only three PKS gene clusters, which is consistent with the strain's
relatively rapid, high-titer candicidin fermentation capability.
Additionally, the smaller and thus relatively simple genome of
Streptomyces sp. FR-008 is ideally structured for genome-scale
modeling. The rapid growth potential of Streptomyces sp. FR-008,
in combination with the optimized conjugation system we devel-
oped and the promoter elements we characterized as ideally suited
for heterologous expression, suggest that this strain would be an
useful chassis. The rapid growth rate and amenability to the
transfer of exogenesis genes provides a platform for simpler and
less time-consuming heterologous expression without a loss of
efﬁciency.
To provide for a less complex genomic and transcriptomic
background, we deleted the PKS gene clusters located in the 0.53-
Mb right subtelomeric region of the Streptomyces sp. FR-008
chromosome. Considering that the genome architecture could be
affected by both the linear composition and three-dimensional
structure of the chromosome, LQ3 was generated by sequential
deletion of the three PKS gene clusters. Strain LQ3 thus represents
an “updated” version of Streptomyces sp. FR-008, with a more stable
and streamlined genome. The minimization of secondary metab-
olite production in LQ3 provides for simpler and more effective
separation and puriﬁcation processes. Similar to S. coelicolorM1152
and its parental strain, S. coelicolor M14, LQ3 lacks three native
biosynthetic gene clusters compared with Streptomyces sp. FR-008,
thus providing for heterologous expression yields that are dozens
of times higher than those of the parental strain [11]. Combined
with the convenient genetic operation system and ﬁne-tuning of
transcriptional control elements, further ‘plug-and-play’ manipu-
lation of this chassis could be carried out to increase its metabolic
potential.
5. Conclusion
Expressing heterologous native drug biosynthesis genes in
easily manipulated host cells can overcome the unfavorable char-
acteristics of many native producing organisms, which are often
difﬁcult to culture and manipulate genetically. The use of more
amenable, well-characterized surrogate host organisms to express
cryptic gene clusters from un-culturable strains could facilitate the
production of novel chemicals. The availability of a well-
characterized, fast growing, and genetically pliable organism as a
biosynthesis “chassis” would greatly enhance the success of het-
erologous expression efforts. We evaluated the potential of Strep-
tomyces sp. FR-008 to serve as an emerging chassis. We conducted
genome sequencing and transcriptome analyses, developed a
simpliﬁed conjugation method, and identiﬁed strong promoters to
produce an improved PKS gene knockout mutant suitable as a
platform for the expression of exogenous genes for a variety of
biotechnology applications.Acknowledgments
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